Porton Pharma Solutions Cash Flow Statement

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022
Net Income	30.39	-287.75	266.86	2,005	523.92
Depreciation & Amortization	426.21	395.59	349.11	259.67	192.2
Other Amortization	46.58	50.22	30.27	6.88	4.26
Loss (Gain) From Sale of Assets	1.17	0.77	-0.54	-0.1	3.21
Asset Writedown & Restructuring Costs	40.26	92.57	58.13	18.63	16.22
Loss (Gain) From Sale of Investments	2.79	49.24	7.76	28.18	6.79
Provision & Write-off of Bad Debts	-	20.28	-35.24	33.12	43.47
Other Operating Activities	99.68	11.69	23.12	-50.74	-1.13
Change in Accounts Receivable	-80.21	-80.55	954.72	-330.48	-736.71
Change in Inventory	-38.21	-105.9	130.04	-163.58	-315.56
Change in Accounts Payable	191.39	289.92	-1,173	732.54	756.73
Operating Cash Flow	757.01	405.53	629.06	2,564	480.17
Operating Cash Flow Growth	86.67%	-35.53%	-75.47%	434.06%	-4.80%
Capital Expenditures	-292.57	-490.58	-1,130	-1,173	-776.97
Sale of Property, Plant & Equipment	3.95	2.53	2.35	1.34	6.99
Cash Acquisitions	-	-	-	-233.33	-171.1
Investment in Securities	-403.21	-15	-20	-26.5	15.51
Other Investing Activities	13.98	3.1	32.76	-4.65	9.4
Investing Cash Flow	-677.84	-499.95	-1,115	-1,436	-916.17
Long-Term Debt Issued	220.41	237.98	1,119	1,345	414.64
Long-Term Debt Repaid	-604.01	-328.64	-574.14	-1,266	-353.43
Total Debt Repaid	-604.01	-328.64	-574.14	-1,266	-353.43
Net Debt Issued (Repaid)	-383.6	-90.66	544.43	78.19	61.2
Issuance of Common Stock	-	-	1.21	16.1	65.01
Repurchase of Common Stock	-	-9.87	-19.39	-100	-
Common Dividends Paid	-30.11	-301.5	-626.57	-129.08	-82.76
Other Financing Activities	-80.21	-11.71	-28.22	395.63	306.76
Financing Cash Flow	-493.92	-413.74	-128.54	260.84	350.22
Foreign Exchange Rate Adjustments	-11.16	4.51	55.29	49.04	-9.05
Net Cash Flow	-425.91	-503.66	-558.95	1,438	-94.83
Free Cash Flow	464.45	-85.06	-500.81	1,391	-296.8
Free Cash Flow Margin	13.58%	-2.82%	-13.66%	19.78%	-9.56%
Free Cash Flow Per Share	0.87	-0.16	-0.92	2.56	-0.55
Cash Income Tax Paid	-1.34	-67.14	30.17	-137.27	-73.82
Levered Free Cash Flow	260.09	-157.27	-1,174	905.7	-513.5
Unlevered Free Cash Flow	260.09	-118.48	-1,146	923.03	-499.94
Change in Working Capital	109.93	72.91	-70.41	263.33	-308.76

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.